Context Therapeutics is trading at $0.56 (down approx. 18.8% from its daily close of $0.69) in after-hours as investors react to upcoming Q2 2026 earnings. * The company is projected to release Q2 2026 earnings before market open on August 5, 2026. * The after-hours decline appears to be cautious positioning ahead of key financial results. * The stock had rallied significantly, closing up 11.45% on August 5, 2026.